This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Irene E. Waskow, PhD; James E. Olsson, PhD; Carl Salzman, MD; Martin M. Katz, PhD

Arch Gen Psychiatry. 1970;22(2):97-107.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE MORE widespread use of marihuana and marihuana-like drugs in the general population and the controversy about their possible harmful, as well as beneficial, effects have led to an increased interest in studying these compounds during the last few years. At the same time, the identification of l-¹-3,4 trans-tetrahydrocannabinol (THC) as a constituent of marihuana and its synthesis by Gaoni and Mechoulam^1,2 have made possible the systematic study of this substance, which is presumed to be the most active element in marihuana (l-¹ is also referred to as l-⁹; l-¹ follows terpene nomenclature, which was used by Mechoulam and Gaoni, whereas l-⁹ follows standard chemical abstracts nomenclature).

The major aim of the present study is the delineation of some of the psychological effects of THC. This paper will deal primarily with the systematic measurement of . . . [Full Text PDF of this Article]

Author Affiliations
Chevy Chase, Md

From the Special Studies Section, Psychopharmacology Research Branch, National Institute of Mental Health, Chevy Chase, Md. Dr. Olsson is currently with the Medical Office, Supreme Bench of Baltimore, and Dr. Salzman is currently with the Massachusetts Mental Health Center, and Harvard Medical School, Boston. Drs. Waskow and Katz are currently with the Clinical Research Branch, NIMH, Chevy Chase, Md.

Footnotes
Submitted for publication July 29, 1969.

Read in part before the American College of Neuropsychopharmacology, San Juan, PR, Dec 19, 1968.

Reprint requests to Clinical Research Branch, Division of Extramural Research Programs, NIMH, 5454 Wisconsin Ave, Chevy Chase, Md (Dr. Waskow).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?